| Recent insight into intermediate filament structure SA Eldirany, IB Lomakin, M Ho, CG Bunick Current opinion in cell biology 68, 132-143, 2021 | 82 | 2021 |
| Update of the keratin gene family: evolution, tissue-specific expression patterns, and relevance to clinical disorders M Ho, B Thompson, JN Fisk, DW Nebert, EA Bruford, V Vasiliou, ... Human Genomics 16, 1-21, 2022 | 65 | 2022 |
| Human keratin 1/10‐1B tetramer structures reveal a knob‐pocket mechanism in intermediate filament assembly SA Eldirany, M Ho, AJ Hinbest, IB Lomakin, CG Bunick The EMBO journal 38 (11), e100741, 2019 | 42 | 2019 |
| ARID1A‐SIN3A drives retinoic acid‐induced neuroblastoma differentiation by transcriptional repression of TERT CB Bui, HK Le, DM Vu, KDD Truong, NM Nguyen, MAN Ho, DQ Truong Molecular Carcinogenesis 58 (11), 1998-2007, 2019 | 20 | 2019 |
| Focus: Skin: Crystal Structure of Keratin 1/10 (C401A) 2B Heterodimer Demonstrates a Proclivity for the C-Terminus of Helix 2B to Form Higher Order Molecular Contacts IB Lomakin, AJ Hinbest, M Ho, SA Eldirany, CG Bunick The Yale Journal of Biology and Medicine 93 (1), 3, 2020 | 14 | 2020 |
| An ubiquitin-binding molecule can work as an inhibitor of ubiquitin processing enzymes and ubiquitin receptors T Nguyen, M Ho, A Ghosh, T Kim, SI Yun, SS Lee, KK Kim Biochemical and biophysical research communications 479 (1), 33-39, 2016 | 12 | 2016 |
| Structural Basis for p19 Targeting by Anti–IL-23 Biologics: Correlations with Short-and Long-Term Efficacy in Psoriasis SG Daniele, SA Eldirany, G Damiani, M Ho, CG Bunick JID Innovations 4 (2), 100261, 2024 | 9* | 2024 |
| The interface between keratin structurotype and human disease SA Eldirany, M Ho, CG Bunick Structure 28 (3), 271-273, 2020 | 8 | 2020 |
| Chemical, biochemical, and structural similarities and differences of dermatological cAMP phosphodiesterase-IV inhibitors J Wang, M Ho, CG Bunick Journal of Investigative Dermatology, 2024 | 6 | 2024 |
| Focus: skin: structural basis for how biologic medicines bind their targets in psoriasis therapy SA Eldirany, M Ho, CG Bunick The Yale Journal of Biology and Medicine 93 (1), 19, 2020 | 6 | 2020 |
| Molecular modeling of pathogenic mutations in the keratin 1B domain AJ Hinbest, SA Eldirany, M Ho, CG Bunick International Journal of Molecular Sciences 21 (18), 6641, 2020 | 5 | 2020 |
| Suppression of the ubiquitin pathway by small molecule binding to ubiquitin enhances doxorubicin sensitivity of the cancer cells T Nguyen, M Ho, K Kim, SI Yun, P Mizar, JW Easton, SS Lee, KK Kim Molecules 24 (6), 1073, 2019 | 5 | 2019 |
| Altered skin microbiome, inflammation, and JAK/STAT signaling in Southeast Asian ichthyosis patients M Ho, HN Nguyen, M Van Hoang, TTT Bui, BQ Vu, THT Dinh, HTM Vo, ... Human Genomics 18 (1), 38, 2024 | 4 | 2024 |
| Structural properties of target binding by profilaggrin A and B domains and other S100 fused-type calcium-binding proteins AJ Hinbest, SR Kim, SA Eldirany, IB Lomakin, J Watson, M Ho, CG Bunick Journal of dermatological science 100 (1), 39-49, 2020 | 4 | 2020 |
| Unveiling the secrets of vimentin filament architecture relevant to human disease IB Lomakin, M Ho, CG Bunick Nature Structural & Molecular Biology, 1-3, 2024 | 3 | 2024 |
| Optimized Second-Generation IL-4Rα Inhibition: Structural and Molecular Dynamics Properties of Rademikibart Fab-IL-4Rα Complex Y Shi, M Ho, H Li, R Collazo, C Bunick SKIN The Journal of Cutaneous Medicine 8 (6), s452-s452, 2024 | | 2024 |
| Compositions and Methods for Inhibiting Intermediate Filament Tetramerization C Bunick, S Eldirany, M Ho US Patent App. 17/283,405, 2021 | | 2021 |
Christopher BunickYale UniversityVerified email at yale.edu